Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This study evaluates the use of the standard treatment R-CHOP plus the anti-VEGF drug, bevacizumab and whether this treatment is feasible in patients with stage II, III and IV diffuse large B cell lymphoma (DLBCL).
Critère d'inclusion
- Non-Hodgkin's Lymphoma,B-cell lymphoma